Clinical Trials and Studies
The University of Florida (UF) Diabetes Center of Excellence is an international leader in type 1 diabetes research. Our team is dedicated to understanding the causes of type 1 diabetes and investigating therapies to treat and ultimately cure the disease.
Key to this mission is collaborative research between scientists who work in the laboratory and physicians who work directly with patients. This “bench-to-bedside” model means that scientific findings in the laboratory can be translated into medical treatments with the potential to benefit those who live with diabetes. We hope to learn how to prevent type 1 diabetes by gaining a clear understanding of the interplay between genetic predisposition and environmental triggers. We also seek to test safe, innovative new therapies that might mitigate beta cell destruction and reduce the person’s dependence on insulin.
Principal Investigators for Clinical Studies and Trials
- Mark Atkinson, PhD
- Michael Clare-Salzler, MD
- Michael Haller, MD
- Desmond Schatz, MD
- Janet Silverstein, MD
- Chang Qing Xia, MD, PhD
Contact Information
For more information about clinical trials at the University of Florida Diabetes Center of Excellence, please contact:
Annie Abraham
Recruitment Coordinator
Diabetes Research Group
University of Florida
Box 100296 Gainesville, FL 32610
Phone: 877-343-2377
Direct line: 352-334-1358
Fax: 352-334-1777
Email: aabra@peds.ufl.edu